Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Anavex Lf SC
(NQ:
AVXL
)
3.815
+0.105 (+2.83%)
Streaming Delayed Price
Updated: 12:09 PM EDT, May 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Anavex Lf SC
< Previous
1
2
Next >
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, Anavex, and Innoviz and Encourages Investors to Contact the Firm
March 22, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corp. (AVXL) Investors
March 21, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corp. (AVXL) Investors
March 21, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
March 21, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
AVXL INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Anavex Life Sciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
March 19, 2024
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, and Anavex and Encourages Investors to Contact the Firm
March 18, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Anavex Life Sciences Corporation Stockholder Alert: Robbins LLP Reminds Investors of AVXL Class Action
March 18, 2024
From
Robbins LLP
Via
Business Wire
ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Anavex Life Sciences Corporation
March 18, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
ANAVEX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. and Encourages Investors to Contact the Firm
March 14, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Anavex Life Sciences Corporation (AVXL)
March 14, 2024
From
Robbins LLP
Via
GlobeNewswire
AVXL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
March 14, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ANAVEX LIFE SCIENCES CORPORATION SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corporation (NASDAQ: AVXL)
March 14, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Class Action Lawsuit Filed on Behalf of Anavex Life Sciences Corp. (AVXL) Investors - Nationally Ranked Investors Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
March 14, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Class Action Lawsuit Filed on Behalf of Anavex Life Sciences Corp. (AVXL) Investors - Nationally Ranked Investors Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
March 14, 2024
ATLANTA, GA - (NewMediaWire) - March 14, 2024 - A shareholder class action lawsuit has been filed against Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL). The lawsuit alleges that...
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
AVXL INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Anavex Life Sciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
March 14, 2024
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Anavex Life Sciences (NASDAQ: AVXL) Says Phase 2b/3 for ANAVEX2-73 Met Primary and Secondary Endpoints Reducing Cognative Decline in Patients with Early Alzheimer’s
December 02, 2022
Anavex Life Sciences Corp. (NASDAQ: AVXL) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and
Via
Spotlight Growth
Exposures
Product Safety
Alzheimer’s Pipeline of New Treatments Race to Improve Quality of Life for Patients
October 20, 2022
Palm Beach, FL – October 20, 2022 – FinancialNewsMedia.com News Commentary – Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, (AD) which...
Via
FinancialNewsMedia
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors With Losses to Inquire About Securities Class Action Investigation – AVXL
April 05, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
Anavex Life Sciences Corp. (NASDAQ:AVXL) Investor Alert: Investigation over Potential Wrongdoing
March 21, 2022
San Diego, CA -- (SBWIRE) -- 03/21/2022 -- An investigation on behalf of investors in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) was announced over potential breaches of fiduciary duties by...
Via
SBWire
NASDAQ:AVXL Shareholder Notice: Investigation over Potential Securities Laws Violations by Anavex Life Sciences Corp.
February 23, 2022
San Diego, CA -- (SBWIRE) -- 02/23/2022 -- Anavex Life Sciences Corp. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
February 04, 2022
Los Angeles - (NewMediaWire) - February 04, 2022 - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Anavex Life...
Via
NewMediaWire
Investigation Notice: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
February 03, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ANAVEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Anavex Stockholders and Encourages Investors to Contact the Firm
February 02, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
February 02, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
February 02, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Anavex Life Sciences Corp. (AVXL) on Behalf of Investors
February 02, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm
February 02, 2022
From
The Schall Law Firm
Via
Business Wire
Alzheimer’s Treatment Market Is Anticipated To Reach $2 Billion By The End Of 2027
June 24, 2021
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Global Glioblastoma Multiforme (GBM) Treatment Market Could Reach Nearly $1.8 Billion By 2027
June 29, 2021
Via
FinancialNewsMedia
Global Dementia Drugs Market Expected to Exceed $19.6 Billion In 2026
April 20, 2021
Via
FinancialNewsMedia
Topics
Death
Exposures
COVID-19
Death
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.